| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/05/2002 | US6344453 Insecticidal heterocyclic compounds |
| 02/05/2002 | US6344450 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 01/31/2002 | WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 01/31/2002 | WO2002008232A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/31/2002 | WO2002008225A1 2-(1h-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity |
| 01/31/2002 | WO2002008224A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | WO2002008222A2 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS |
| 01/31/2002 | WO2002008212A1 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 01/31/2002 | WO2002008203A2 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4 |
| 01/31/2002 | WO2002008200A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 01/31/2002 | WO2002008185A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | US20020013485 Cytotoxic agents comprising taxanes and their therapeutic use |
| 01/31/2002 | US20020013460 Condensed pyridine compound |
| 01/31/2002 | US20020013348 For prophylaxis and therapy of asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis, infection by HIV, delaying of the onset of AIDS |
| 01/31/2002 | US20020013341 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, Bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition |
| 01/31/2002 | US20020013326 For controlling harmful insects, acarina and nematodes |
| 01/31/2002 | US20020013323 Oxadiazole and thiadiazole derivatives of dihydropyridine NPY antagonists |
| 01/31/2002 | US20020013321 Used as ligands for opioid receptors, for therapy of neurological and gastrointestinal disorders |
| 01/31/2002 | US20020013314 For treating or preventing thrombosis |
| 01/31/2002 | US20020012977 Enzymatic oxidations |
| 01/31/2002 | DE10035144A1 Cyclische Aminosäurederivate Cyclic amino acid derivatives |
| 01/31/2002 | DE10034801A1 Substituierte Amidoalkyl-uracile und ihre Verwendung Substituted amidoalkyl uracils and their use |
| 01/31/2002 | DE10034800A1 Substituierte Benzostickstoffheterocyclen Substituted Benzostickstoffheterocyclen |
| 01/31/2002 | DE10034628A1 New thienyl and benzothienyl substituted oxazolidinone derivatives useful as TNF alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, adult respiratory distress syndrome and psoriasis |
| 01/31/2002 | DE10034627A1 New cyclic hydrocarbyl substituted oxazolidinone derivatives useful as tumor necrosis factor-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, cardiac infarction and psoriasis |
| 01/31/2002 | DE10034625A1 New aryl substituted thienyl-oxazolidinone derivatives useful as tumor necrosis factor-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, transplant rejection and psoriasis |
| 01/31/2002 | DE10034624A1 New aryl substituted thienyl-oxazolidinone derivatives useful as tumor necrosis facto-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, cardiac infraction and psoriasis |
| 01/31/2002 | DE10034623A1 New heterocyclic substituted pyridine derivatives useful as tumor necrosis factor-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, transplant rejection and psoriasis |
| 01/31/2002 | DE10034622A1 New aralkyl substituted imidazole derivatives useful as tumor necrosis factor-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, transplant rejection and psoriasis |
| 01/31/2002 | CA2417192A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | CA2417189A1 2-(1h-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity |
| 01/31/2002 | CA2415740A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | CA2415046A1 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 01/31/2002 | CA2354236A1 Use of glycogen phosphorylase inhibitors to inhibit tumor growth |
| 01/30/2002 | EP1176144A1 N-triazolylmethyl-piperazine derivatives as neurokinine receptor-antagonists |
| 01/30/2002 | EP1176141A1 HETEROCYCLIC COMPOUNDS HAVING EFFECT OF ACTIVATING NICOTINIC ACETYLCHOLINE $g(a)4$g(b)2 RECEPTOR |
| 01/30/2002 | EP1176139A1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 01/30/2002 | EP1175419A2 Aryl sulfonyls as factor xa inhibitors |
| 01/30/2002 | EP1175417A1 Substituted benzolactam compounds |
| 01/30/2002 | EP1175413A1 2,1-benzisothiazoline 2,2-dioxides |
| 01/30/2002 | EP1175412A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 01/30/2002 | EP1175411A1 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 01/30/2002 | EP1175406A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands |
| 01/30/2002 | EP1175404A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 01/30/2002 | EP1175402A1 Piperidine derivatives useful as ccr5 antagonists |
| 01/30/2002 | EP1175401A1 Piperazine derivatives useful as ccr5 antagonists |
| 01/30/2002 | EP1175399A1 Inhibitors of c-jun n-terminal kinases (jnk) |
| 01/30/2002 | EP1175383A1 Glucocorticoid receptor modulators |
| 01/30/2002 | EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/30/2002 | EP0922043B1 Pesticidal 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazoles |
| 01/30/2002 | EP0836602B1 Fungicidal pyrimidinones |
| 01/30/2002 | EP0740689B1 Substituted unsymmetrical cyanine dyes with selected permeability |
| 01/30/2002 | CN1333771A Benzoxazole derivatives and druges containing the same as the active ingredient |
| 01/30/2002 | CN1333770A Novel dicyclic compound |
| 01/30/2002 | CN1333767A Aromatic heterocyclic compounds as antiinflammatory agent |
| 01/30/2002 | CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors |
| 01/30/2002 | CN1333760A Novel heterocyclic compounds and drug compositions containing the same |
| 01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
| 01/30/2002 | CN1333753A Quinolinecarboxamides as antiviral agents |
| 01/29/2002 | US6342610 Compounds such as n-(4-bromo-3-methyl-5-isoxazolyl)-2-n-benzylbenzo(b)thiophene-3-sufonamide administered as endothelin peptide receptor antagonists |
| 01/29/2002 | US6342608 Reacting organometallic reagent with activated carboxylic acid to form ketone, treating with mixture of carbon disulfide and dihalomethane to form dithietane, reacting with hydrazine derivative to form thiol-substituted pyrazole, alkylating |
| 01/29/2002 | US6342599 1,3,4-oxadiazine derivatives and their use as pesticides |
| 01/29/2002 | US6342513 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 01/29/2002 | US6342245 Compositions of lipid lowering agents |
| 01/29/2002 | CA2165996C Stereoselective preparation of 2-substituted succinic derivatives |
| 01/24/2002 | WO2002006280A2 INHIBITORS OF FACTOR Xa |
| 01/24/2002 | WO2002006278A1 Oxazolidinone derivatives as antimicrobials |
| 01/24/2002 | WO2002006277A1 Substituted benzo-nitro-heterocycles and use thereof as herbicides |
| 01/24/2002 | WO2002006276A1 Beta3 adrenergic agonists |
| 01/24/2002 | WO2002006270A1 Novel 6-heteroarylphenanthridines |
| 01/24/2002 | WO2002006256A1 Heterocyclic fluoroalkenyl thioethers (ii) |
| 01/24/2002 | WO2002006255A2 Hydroxy-(piperidin-4-yl-methylamino)-alkyl beta-3 adrenergic receptor antagonists |
| 01/24/2002 | WO2002006250A1 Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists |
| 01/24/2002 | WO2002006248A2 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 01/24/2002 | WO2002006247A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 01/24/2002 | WO2002006246A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 01/24/2002 | WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/24/2002 | WO2002006236A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 01/24/2002 | WO2002006232A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 01/24/2002 | WO2002006222A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/24/2002 | WO2002006211A1 Preparation of 4-thioalkylbromobenzene derivatives |
| 01/24/2002 | WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 01/24/2002 | WO2001032655A3 Quinoline and naphthyridine carboxylic acid antibacterials |
| 01/24/2002 | WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method |
| 01/24/2002 | US20020010345 Methods for the preparation of 4-hydroxy benzothiophene |
| 01/24/2002 | US20020010343 Compounds having IgE affecting properties |
| 01/24/2002 | US20020010341 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
| 01/24/2002 | US20020010315 Treatment or amelioration of symptoms of adult respiratory distress syndrome, septic shock, and multiple organ failure. |
| 01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
| 01/24/2002 | US20020010186 Dihydropyrimidines and uses thereof |
| 01/24/2002 | US20020010181 Angiogenesis inhibitors as antitumor agents |
| 01/24/2002 | US20020010177 For treating eosinophil-dependent inflammatory diseases, asthma |
| 01/24/2002 | US20020010098 Insecticides, nematodicides |
| 01/24/2002 | US20020009483 Topical administration of oxazolidinones for transdermal delivery |
| 01/24/2002 | US20020007522 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 01/24/2002 | US20020007521 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 01/24/2002 | DE10034154A1 Multifunktionelle Kopplungsagenzien mit zyklischen Iminoester- und Iminoethergruppen, Verfahren zu deren Herstellung und Verwendung Multifunctional coupling with cyclic iminoester and iminoether groups, process for their preparation and use |
| 01/24/2002 | DE10034131A1 Heterocyclische Fluoralkenylthioether (II) Heterocyclic fluoroalkenyl thioethers (II) |